Article
Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance.
Epilepsia - 1 Jan 2007
Glauser Tracy A
Abstract excerpt
A novel and potentially effective way to decrease pharmacoresistance is to widen an antiepileptic drug's (AED) safety window by altering its efficacy-toxicity relationship to reduce the frequency or eliminate the occurrence of drug-induced toxicities. The first step in this process is to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
